#cfg-920

[amcrasto]

CFG 920, Novartis Scientists team up with Researchers at Aurigene, Bangalore, India,

CFG 920, Novartis Scientists team up with Researchers at Aurigene, Bangalore, India,

CFG920, Inhibitor Of Prostate Cancer With Fewer Cardiac Side Effects Cas 1260006-20-9 Novartis Target: CYP17/CYP11B2 Disease: Castration-resistant prostate cancer MF C14H13ClN4O MW: 288.0778 Elemental Analysis: C, 58.24; H, 4.54; Cl, 12.28; N, 19.40; O, 5.54 Steroid 17-alpha-hydroxylase inhibitors CFG920 is a CYP17 inhibitor, is also an orally available inhibitor of the steroid…

View On WordPress

[amcrasto]

CFG 920, Novartis scientists team up with researchers at Aurigene, Bangalore, India,

CFG 920, Novartis scientists team up with researchers at Aurigene, Bangalore, India,

CFG920, INHIBITOR OF Prostate Cancer With Fewer Cardiac Side Effects

Cas 1260006-20-9

Novartis Target: CYP17/CYP11B2 Disease: Castration-resistant prostate cancer

MF C14H13ClN4O MW: 288.0778

Elemental Analysis: C, 58.24; H, 4.54; Cl, 12.28; N, 19.40; O, 5.54

Steroid 17-alpha-hydroxylase inhibitors

CFG920 is a CYP17 inhibitor, is also an orally available inhibitor of the steroid…

View On WordPress